Literature DB >> 1838578

Alzheimer's disease: beta-amyloid precursor protein mRNA expression in mononuclear blood cells.

J S Allen1, G M Murphy, L F Eng, K E Stultz, H D Davies, L B Pickford, J R Tinklenberg.   

Abstract

beta-Amyloid precursor protein (beta APP) mRNA was examined in peripheral mononuclear blood cells (PMBCs) in Alzheimer's disease, Down's syndrome and control subjects. Total RNA from PMBCs was reverse transcribed and then amplified using the polymerase chain reaction (PCR). The 3 major beta APP transcripts were expressed in PMBCs from all subjects. These results suggest that PMBCs could be a circulating source for abnormal amyloid deposition in the brain and in peripheral tissues.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1838578     DOI: 10.1016/0304-3940(91)90445-y

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

1.  Immunophenotypes in the circulation of patients with mild cognitive impairment.

Authors:  Shino Magaki; Steven M Yellon; Claudius Mueller; Wolff M Kirsch
Journal:  J Psychiatr Res       Date:  2007-02-23       Impact factor: 4.791

2.  Increased production of inflammatory cytokines in mild cognitive impairment.

Authors:  Shino Magaki; Claudius Mueller; Cindy Dickson; Wolff Kirsch
Journal:  Exp Gerontol       Date:  2006-11-07       Impact factor: 4.032

Review 3.  Microvascular pathology and vascular basement membrane components in Alzheimer's disease.

Authors:  L S Perlmutter
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

Review 4.  Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria.

Authors:  Judith Miklossy
Journal:  J Neuroinflammation       Date:  2011-08-04       Impact factor: 8.322

Review 5.  Common mechanisms involved in Alzheimer's disease and type 2 diabetes: a key role of chronic bacterial infection and inflammation.

Authors:  Judith Miklossy; Patrick L McGeer
Journal:  Aging (Albany NY)       Date:  2016-04       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.